PMID- 30085016 OWN - NLM STAT- MEDLINE DCOM- 20190320 LR - 20220330 IS - 1876-4479 (Electronic) IS - 1873-9946 (Print) IS - 1873-9946 (Linking) VI - 12 IP - 12 DP - 2018 Nov 28 TI - C/EBPbeta Deletion Promotes Expansion of Poorly Functional Intestinal Regulatory T Cells. PG - 1475-1485 LID - 10.1093/ecco-jcc/jjy105 [doi] AB - BACKGROUND AND AIMS: Inflammatory Bowel Diseases [IBDs] are chronic intestinal inflammatory conditions in part mediated by CD4+ T cells. Anti-inflammatory Foxp3+ regulatory T cells [Tregs] maintain immune homeostasis and protect against IBD development via multiple mechanisms, including cytokine secretion and cell-cell interaction. CCAAT enhancer binding protein-beta [C/EBPbeta] is a stress-responsive transcription factor linked with IBD susceptibility. Whole-body C/EBPbeta deficiency induces CD4+ T cell-predominant hyperproliferation, and we hypothesize that this may be due to impaired Treg function. METHODS: We used the C/EBPbeta-/- mice in the CD45RBHigh adoptive transfer model, to assess C/EBPbeta-/- CD4+ T cells for their colitiogenic potential, and C/EBPbeta-/- CD4+ Foxp3+ Tregs for their ability to inhibit colitis. We assessed Tregs from the C/EBPbeta-/- mice for expression of Treg functional genes and proteins. RESULTS: Naive C/EBPbeta-/- CD4+ T cells are more colitogenic in vivo. The exacerbated colitis does not appear to reflect impaired Treg development, however, as C/EBPbeta-/- mice displayed more, rather than fewer intestinal CD4+Foxp3+ Tregs in vivo. Instead, this reflects impaired Treg function as seen by the reduced capacity to suppress T cell proliferation in vitro, along with decreased secretion of the anti-inflammatory cytokine IL-10. These findings were corroborated in vivo by additional adoptive co-transfer studies in which wildtype Tregs prevented colitis but C/EBPbeta-/- Tregs did not. CONCLUSION: C/EBPbeta deficiency impairs Treg function and potentiates T cell-mediated colitis. A clearer understanding of the function of this transcription factor may provide a novel therapeutic strategy for IBD. FAU - Collins, Colm B AU - Collins CB AD - Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA. AD - Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. AD - Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, USA. FAU - Puthoor, Pamela R AU - Puthoor PR AD - Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA. AD - Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. AD - Pediatric Inflammatory Bowel Disease Center, Children's Hospital Colorado, Aurora, CO, USA. FAU - Nguyen, Tom T AU - Nguyen TT AD - Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA. AD - Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. AD - Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, USA. FAU - Strassheim, Derek AU - Strassheim D AD - Department of Medicine, University of Colorado, Aurora, CO, USA. FAU - Jedlicka, Paul AU - Jedlicka P AD - Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA. FAU - Friedman, Jacob E AU - Friedman JE AD - Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. FAU - de Zoeten, Edwin F AU - de Zoeten EF AD - Section of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA. AD - Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. AD - Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, USA. AD - Pediatric Inflammatory Bowel Disease Center, Children's Hospital Colorado, Aurora, CO, USA. LA - eng GR - K08 DK080189/DK/NIDDK NIH HHS/United States PT - Journal Article PL - England TA - J Crohns Colitis JT - Journal of Crohn's & colitis JID - 101318676 RN - 0 (CCAAT-Enhancer-Binding Protein-beta) RN - 0 (Cytokines) SB - IM EIN - J Crohns Colitis. 2019 Apr 26;13(5):672. PMID: 30624617 MH - Animals MH - CCAAT-Enhancer-Binding Protein-beta/*metabolism MH - CD4-Positive T-Lymphocytes/*immunology MH - *Colitis/immunology/pathology MH - Cytokines/metabolism MH - Gene Deletion MH - *Inflammation/immunology/pathology MH - *Inflammatory Bowel Diseases/immunology/pathology MH - Mice MH - Signal Transduction MH - T-Lymphocytes, Regulatory/*immunology PMC - PMC8877170 EDAT- 2018/08/08 06:00 MHDA- 2019/03/21 06:00 PMCR- 2018/07/31 CRDT- 2018/08/08 06:00 PHST- 2018/08/08 06:00 [pubmed] PHST- 2019/03/21 06:00 [medline] PHST- 2018/08/08 06:00 [entrez] PHST- 2018/07/31 00:00 [pmc-release] AID - 5062721 [pii] AID - jjy105 [pii] AID - 10.1093/ecco-jcc/jjy105 [doi] PST - ppublish SO - J Crohns Colitis. 2018 Nov 28;12(12):1475-1485. doi: 10.1093/ecco-jcc/jjy105.